Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Evolution of the Cancer Stem Cell Model
2014 Standout
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
2004 Standout
New data on robustness of gene expression signatures in leukemia: comparison of three distinct total RNA preparation procedures
2007
Cancer treatment and survivorship statistics, 2022
2022 Standout
AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis
1996 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Partial chromosome 21 amplification in a child with acute lymphoblastic leukemia
1995
Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer
2016
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
Current management and challenges of malignant disease in the CNS in paediatric leukaemia
2008
Inhibition of FLT3 in MLL
2003
Secondary leukemias induced by topoisomerase-targeted drugs
1998
NCI Thesaurus: A semantic model integrating cancer-related clinical and molecular information
2006
Cytogenetics in acute leukemia
2003
Acute Lymphoblastic Leukemia
1998
Acute lymphoblastic leukaemia
2013
GSVA: gene set variation analysis for microarray and RNA-Seq data
2013 Standout
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development
1994 StandoutNobel
Optimization of minuscule samples for use with cDNA microarrays
2007 StandoutNobel
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
2001
MLL–AF9-mediated immortalization of human hematopoietic cells along different lineages changes during ontogeny
2012
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
1999
Patient Adherence and Medical Treatment Outcomes
2002 Standout
Survival of children and adolescents with acute lymphoid leukemia. A study of American Indians and Hispanic and non-Hispanic whites treated in New Mexico (1969 to 1986)
1991
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
2003
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
The effects of infection prevention regimens on early infectious complications in marrow transplant patients: A four arm randomized study
1988 StandoutNobel
Childhood Leukemias
1995
The Management of Neoplastic Disorders of Haematopoeisis in Children with Down's Syndrome
2000
Clinical and biological importance of cytogenetic abnormalities in childhood and adult acute lymphoblastic leukemia
2004
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Down's syndrome
2003 Standout
Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study.
1993
CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo
2017 StandoutNobel
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
1991 Standout
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Lessons from the past: Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies
2011
Molecular diagnosis of lymphoid malignancies by gene expression profiling
2002
Childhood acute lymphoblastic leukemia
2002
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
Integrating cell-signalling pathways with NF-κB and IKK function
2006 Standout
The impact of induction anthracycline on long‐term failure‐free survival in childhood acute lymphoblastic leukemia
1986
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myeloid Leukemia in Children: An Evidence-Based Review
2007
Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting
2010
Allogeneic Marrow Transplantation
1984
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86
1994
Childhood and adolescent cancer statistics, 2014
2014 Standout
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways
1998 StandoutNobel
PubChem 2023 update
2022 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
2001 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
The biology and treatment of acute lymphoblastic leukemia in adults
1995
Late Effects of Acute Lymphoblastic Leukemia Therapy in Patients Diagnosed at 0-20 Years of Age
2011
Molecular Genetics of Acute Lymphoblastic Leukemia
2005
Complementing the Genome with an “Exposome”: The Outstanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology
2005 Standout
Current status of cytogenetic research in childhood acute lymphoblastic leukemia
1993
Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations.
1991
Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia
2021 StandoutNobel
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Flow cytometric immunophenotyping for hematologic neoplasms
2008
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital
2004
Cancer treatment and survivorship statistics, 2014
2014 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of CP Steuber being referenced
Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821
2000
A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial
2001
Trisomy 21 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study (8602)
1993
Trisomy 21 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study (8602)
1993
Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study
1982
Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study
1982
Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases [see comments]
1991
Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study
1992
Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study
1992
Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study
1993
Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases [see comments]
1991